Cardiac Resynchronization Therapy Improves Renal Function in Human Heart Failure With Reduced Glomerular Filtration Rate

Journal of Cardiac Failure

Volumn 14, Issue 7, 2008, Pages 539-546

  Boerrigter, Guido ^a   Costello Boerrigter, Lisa C ^a   Abraham, William T ^b   St John Sutton, Martin G ^c   Heublein, Denise M ^a   Kruger, Kristin M ^d   Hill, Michael R S ^d   McCullough, Peter A ^e   Burnett Jr , John C ^a  

^a MAYO CLINIC   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^d MEDTRONIC INC   (United States)

^e Nutr   (United States)

Author keywords

cardiac resynchronization therapy; glomerular filtration rate; Heart failure; natriuretic peptides; neurohormones; renal dysfunction

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UREA NITROGEN BLOOD LEVEL;

ATRIAL NATRIURETIC FACTOR; BLOOD UREA NITROGEN; CARDIAC OUTPUT, LOW; CARDIAC PACING, ARTIFICIAL; CREATININE; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEART FAILURE; HEMATOCRIT; HEMOGLOBINS; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; NATRIURETIC PEPTIDE, BRAIN; PLACEBOS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 49549111147     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2008.03.009     Document Type: Article

References (36)

1. Smith G.L., Lichtman J.H., Bracken M.B., Shlipak M.G., Phillips C.O., DiCapua P., et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 47 (2006) 1987-1996
2. Dries D.L., Exner D.V., Domanski M.J., Greenberg B., and Stevenson L.W. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 35 (2000) 681-689
3. Hillege H.L., Girbes A.R., de Kam P.J., Boomsma F., de Zeeuw D., Charlesworth A., et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102 (2000) 203-210
4. Mahon N.G., Blackstone E.H., Francis G.S., Starling III R.C., Young J.B., and Lauer M.S. The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure. J Am Coll Cardiol 40 (2002) 1106-1113
5. McAlister F.A., Ezekowitz J., Tonelli M., and Armstrong P.W. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 109 (2004) 1004-1009
6. Hillege H.L., Nitsch D., Pfeffer M.A., Swedberg K., McMurray J.J., Yusuf S., et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113 (2006) 671-678
7. Cazeau S., Leclercq C., Lavergne T., Walker S., Varma C., Linde C., et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344 (2001) 873-880
8. Abraham W.T., Fisher W.G., Smith A.L., Delurgio D.B., Leon A.R., Loh E., et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 346 (2002) 1845-1853
9. St John Sutton M.G., Plappert T., Abraham W.T., Smith A.L., DeLurgio D.B., Leon A.R., et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 107 (2003) 1985-1990
10. Bristow M.R., Saxon L.A., Boehmer J., Krueger S., Kass D.A., De Marco T., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
11. Cleland J.G., Daubert J.C., Erdmann E., Freemantle N., Gras D., Kappenberger L., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
12. Cowburn P.J., Patel H., Jolliffe R.E., Wald R.W., and Parker J.D. Cardiac resynchronization therapy: an option for inotrope-supported patients with end-stage heart failure?. Eur J Heart Fail 7 (2005) 215-217
13. Fung J.W., Szeto C.C., Chan J.Y., Zhang Q., Chan H.C., Yip G.W., et al. Prognostic value of renal function in patients with cardiac resynchronization therapy. Int J Cardiol 122 (2007) 10-16
14. Abraham W.T. Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure: the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). J Card Fail 6 (2000) 369-380
15. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
16. Levey A.S., Greene T., Kusek J., and Beck G. A simplified equation to predict glomerular filtration rate from serum creatinine. [abstract]. J Am Soc Nephrol 11 (2000) 155A
17. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 (2002) S1-266
18. Burnett Jr. J.C., Kao P.C., Hu D.C., Heser D.W., Heublein D., Granger J.P., et al. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 231 (1986) 1145-1147
19. Yasue H., Yoshimura M., Sumida H., Kikuta K., Kugiyama K., Jougasaki M., et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90 (1994) 195-203
20. Fonarow G.C., Adams Jr. K.F., Abraham W.T., Yancy C.W., and Boscardin W.J. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 293 (2005) 572-580
21. Burnett Jr. J.C., and Knox F.G. Renal interstitial pressure and sodium excretion during renal vein constriction. Am J Physiol 238 (1980) F279-F282
22. Rodeheffer R.J., Lerman A., Heublein D.M., and Burnett Jr. J.C. Increased plasma concentrations of endothelin in congestive heart failure in humans. Mayo Clin Proc 67 (1992) 719-724
23. Smilde T.D., Hillege H.L., Navis G., Boomsma F., de Zeeuw D., and van Veldhuisen D.J. Impaired renal function in patients with ischemic and nonischemic chronic heart failure: association with neurohormonal activation and survival. Am Heart J 148 (2004) 165-172
24. Cowburn P.J., Patel H., Pipes R.R., and Parker J.D. Contrast nephropathy post cardiac resynchronization therapy: an under-recognized complication with important morbidity. Eur J Heart Fail 7 (2005) 899-903
25. Breithardt O.A., Sinha A.M., Schwammenthal E., Bidaoui N., Markus K.U., Franke A., et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol 41 (2003) 765-770
26. Knaapen P., van Campen L.M., de Cock C.C., Gotte M.J., Visser C.A., Lammertsma A.A., et al. Effects of cardiac resynchronization therapy on myocardial perfusion reserve. Circulation 110 (2004) 646-651
27. Lindner O., Vogt J., Kammeier A., Wielepp P., Holzinger J., Baller D., et al. Effect of cardiac resynchronization therapy on global and regional oxygen consumption and myocardial blood flow in patients with non-ischaemic and ischaemic cardiomyopathy. Eur Heart J 26 (2005) 70-76
28. Lindner O., Sorensen J., Vogt J., Fricke E., Baller D., Horstkotte D., et al. Cardiac efficiency and oxygen consumption measured with 11C-acetate PET after long-term cardiac resynchronization therapy. J Nucl Med 47 (2006) 378-383
29. Steendijk P., Tulner S.A., Bax J.J., Oemrawsingh P.V., Bleeker G.B., van Erven L., et al. Hemodynamic effects of long-term cardiac resynchronization therapy: analysis by pressure-volume loops. Circulation 113 (2006) 1295-1304
30. Grassi G., and Esler M. How to assess sympathetic activity in humans. J Hypertens 17 (1999) 719-734
31. Saxon L.A., De Marco T., Schafer J., Chatterjee K., Kumar U.N., and Foster E. Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling. Circulation 105 (2002) 1304-1310
32. Grassi G., Vincenti A., Brambilla R., Trevano F.Q., Dell'Oro R., Ciro A., et al. Sustained sympathoinhibitory effects of cardiac resynchronization therapy in severe heart failure. Hypertension 44 (2004) 727-731
33. Young J.B., Abraham W.T., Smith A.L., Leon A.R., Lieberman R., Wilkoff B., et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 289 (2003) 2685-2694
34. Adamson P.B., Kleckner K.J., VanHout W.L., Srinivasan S., and Abraham W.T. Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure. Circulation 108 (2003) 266-269
35. Richardson M., Freemantle N., Calvert M.J., Cleland J.G., and Tavazzi L. Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined analysis from the CARE-HF trial. Eur Heart J 28 (2007) 1827-1834
36. Smilde T.D., van Veldhuisen D.J., Navis G., Voors A.A., and Hillege H.L. Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Circulation 114 (2006) 1572-1580